Longevityresearch.ca publishes cross-disease causal analysis quantifying endpoint reduction across 27 diseases
Michimich.com/10333741

TORONTO - Michimich -- An open Bayesian Causal Atlas now reports, for every disease it covers — including non-fatal conditions — the best-case modelled reduction achievable when all applicable beneficial interventions are combined under a Pearl structural-causal framework.

Longevity Research (longevityresearch.ca), an independent quantitative-research project, today released a cross-oracle analysis that computes, for each disease in its Bayesian Causal Atlas, the maximum modelled reduction in that disease's own endpoint when every applicable beneficial intervention is combined at full dose under the project's causal model.

The analysis covers 27 disease models in a single comparable table — spanning all-cause mortality, cardiovascular disease (18 phenotypes), cancer (18 sites), kidney disease, immunology (45 conditions), pulmonary disease, brain tumours, organ transplant, and more — and, unlike most mortality-focused work, it deliberately includes endpoints that are not death: allergy flares, kidney-function decline, disability progression, and other quality-of-life outcomes.

More on Michimich.com

• Ghanaian Afrobeat Artist Praise Kusi Announces Upcoming EP "After 21:00" Releasing July 3, 2026
• TURRENTINE: A Family Legacy United Through Music
• Save 10 Percent Off Summer Stays at KeysCaribbean Resorts
• CGI Announces Pre-Order Launch for New Integrated Behavioral Health Book
• Wayne Rubber Achieves ISO 9001 Certification

Longevity Research is an independent, non-commercial quantitative-research project that applies Bayesian causal inference to the leading causes of mortality and to chronic disease. Its Bayesian Causal Atlas is a free, open set of interactive analyses intended for people managing serious illness, their caregivers, and researchers. The site runs no advertising and collects no user data.

https://longevityresearch.ca/